• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于新型癌症干细胞的结直肠癌肿瘤发生与发展分类模型。

A novel cancer stem cell-based classification model for the tumorigenesis and development of colorectal cancer.

作者信息

Yan Zhaopeng, Wang Rui, Su Qi

机构信息

Department of General Surgery, Shengjing Hospital, China Medical University, Shenyang 110004, China.

Department of Critical Medicine, Shengjing Hospital, China Medical University, Shenyang 110004, China.

出版信息

Transl Cancer Res. 2019 Nov;8(7):2621-2623. doi: 10.21037/tcr.2019.10.19.

DOI:10.21037/tcr.2019.10.19
PMID:35117019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8798201/
Abstract

Cancer is a heterogenetic disease. Although multiple hypotheses and models have been indicated, there is still no robust method to distinguish the heterogeneity of cancer. Evidence has been provided showing that cancer stem cells (CSCs) play an important role in the origin and progression of cancer. In this opinion article, based on the theory of CSCs, we propose a novel CSC-based classification model (CSCCM) to explain the origin and progression of colorectal cancer, which would explain some confusing clinical phenomena and distinguish the heterogeneity of colorectal cancer from its origin. We further suggest that this model can presently be incorporated into the cancer progression theory.

摘要

癌症是一种异质性疾病。尽管已经提出了多种假说和模型,但仍没有可靠的方法来区分癌症的异质性。已有证据表明,癌症干细胞(CSCs)在癌症的发生和发展中起着重要作用。在这篇观点文章中,基于癌症干细胞理论,我们提出了一种新的基于癌症干细胞的分类模型(CSCCM)来解释结直肠癌的发生和发展,这将解释一些令人困惑的临床现象,并从起源上区分结直肠癌的异质性。我们进一步认为,目前该模型可以纳入癌症进展理论。

相似文献

1
A novel cancer stem cell-based classification model for the tumorigenesis and development of colorectal cancer.一种基于新型癌症干细胞的结直肠癌肿瘤发生与发展分类模型。
Transl Cancer Res. 2019 Nov;8(7):2621-2623. doi: 10.21037/tcr.2019.10.19.
2
Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.癌症干细胞异质性:起源及针对癌症干细胞的新观点
BMB Rep. 2017 Mar;50(3):117-125. doi: 10.5483/bmbrep.2017.50.3.222.
3
Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives.结直肠癌中的癌症干细胞:从发病机制到治疗——争议与展望
World J Gastroenterol. 2014 Jan 28;20(4):923-42. doi: 10.3748/wjg.v20.i4.923.
4
A new PDAC mouse model originated from iPSCs-converted pancreatic cancer stem cells (CSCcm).一种源自诱导多能干细胞转化的胰腺癌干细胞(CSCcm)的新型胰腺癌小鼠模型。
Am J Cancer Res. 2016 Dec 1;6(12):2799-2815. eCollection 2016.
5
Insights into the cell of origin in breast cancer and breast cancer stem cells.对乳腺癌起源细胞和乳腺癌干细胞的见解。
Asia Pac J Clin Oncol. 2010 Jun;6(2):89-97. doi: 10.1111/j.1743-7563.2010.01279.x.
6
Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.基于癌症干细胞的结直肠癌模型揭示了治疗抗性的分子决定因素。
Stem Cells Transl Med. 2016 Apr;5(4):511-23. doi: 10.5966/sctm.2015-0214. Epub 2016 Mar 8.
7
Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer.球体形成(结肠球)测定法在结肠癌中用于评估和扩增干细胞的体外试验。
Stem Cell Rev Rep. 2016 Aug;12(4):492-9. doi: 10.1007/s12015-016-9664-6.
8
Cancer stem cells may contribute to the difficulty in treating cancer.癌症干细胞可能导致癌症治疗困难。
Genes Dis. 2016 Feb 10;3(1):7-10. doi: 10.1016/j.gendis.2016.01.001. eCollection 2016 Mar.
9
Stem cells, colorectal cancer and cancer stem cell markers correlations.干细胞、结直肠癌与癌症干细胞标志物的相关性。
Curr Health Sci J. 2014 Jul-Sep;40(3):153-61. doi: 10.12865/CHSJ.40.03.01. Epub 2014 Aug 4.
10
Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.前列腺素 E2 促进小鼠结直肠癌干细胞的扩增和转移。
Gastroenterology. 2015 Dec;149(7):1884-1895.e4. doi: 10.1053/j.gastro.2015.07.064. Epub 2015 Aug 7.

引用本文的文献

1
A "conversion-deterioration-double mutation" theory for the evolution and progression of colorectal cancer.结直肠癌发生发展的“转化-恶化-双重突变”理论。
Cancer Med. 2022 Jul;11(13):2601-2611. doi: 10.1002/cam4.4637. Epub 2022 Mar 13.
2
ZIP7 (SLC39A7) expression in colorectal cancer and its correlation with clinical prognosis.ZIP7(SLC39A7)在结直肠癌中的表达及其与临床预后的相关性。
Transl Cancer Res. 2020 Oct;9(10):6471-6478. doi: 10.21037/tcr-20-2640.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
The consensus molecular subtypes of colorectal cancer.结直肠癌的共识分子亚型
Nat Med. 2015 Nov;21(11):1350-6. doi: 10.1038/nm.3967. Epub 2015 Oct 12.
3
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.一种能够在免疫缺陷小鼠体内引发肿瘤生长的人结肠癌细胞。
Nature. 2007 Jan 4;445(7123):106-10. doi: 10.1038/nature05372. Epub 2006 Nov 19.
4
Identification and expansion of human colon-cancer-initiating cells.人结肠癌起始细胞的鉴定与扩增。
Nature. 2007 Jan 4;445(7123):111-5. doi: 10.1038/nature05384. Epub 2006 Nov 19.
5
Identification of human brain tumour initiating cells.人类脑肿瘤起始细胞的鉴定
Nature. 2004 Nov 18;432(7015):396-401. doi: 10.1038/nature03128.
6
Prospective identification of tumorigenic breast cancer cells.致瘤性乳腺癌细胞的前瞻性鉴定。
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8. doi: 10.1073/pnas.0530291100. Epub 2003 Mar 10.